On November 7, 2019 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, reported that the company plans to present at the following conferences in November (Press release, Iovance Biotherapeutics, NOV 7, 2019, View Source [SID1234550796]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen’s 3rd Annual IO Next Summit in Maryland, Nov. 8, 2019
Location: Gaylord National Resort and Convention Center
Date/Time: Friday, Nov. 8, at 9:30 a.m. EST

Credit Suisse 28th Annual Healthcare Conference in Scottsdale, Ariz., Nov. 11-13, 2019
Location: The Phoenician, Scottsdale
Date/Time: Tuesday, Nov. 12, at 4:45 p.m. MST

Stifel 2019 Healthcare Conference in New York, Nov. 19-21, 2019
Location: Lotte New York Palace Hotel
Date/Time: Tuesday, Nov. 19, at 4:45 p.m. EST

Jefferies 2019 London Healthcare Conferencein London, Nov. 20-21, 2019
Location: The Waldorf Hilton, London
Date/Time: Thursday, Nov. 21, at 9:20 a.m. GMT
Live and archived webcasts of the presentations will be available in the Investors section of the Iovance website at View Source